IS7971A - Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða - Google Patents

Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða

Info

Publication number
IS7971A
IS7971A IS7971A IS7971A IS7971A IS 7971 A IS7971 A IS 7971A IS 7971 A IS7971 A IS 7971A IS 7971 A IS7971 A IS 7971A IS 7971 A IS7971 A IS 7971A
Authority
IS
Iceland
Prior art keywords
erythema
cave
diffuse
peptide
pharmaceutical preparation
Prior art date
Application number
IS7971A
Other languages
English (en)
Inventor
Cohen-Vered Sharon
Naftali Esmira
Weinstein Vera
Gilbert Adrian
Klinger Ety
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/000955 external-priority patent/WO2004064788A2/en
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of IS7971A publication Critical patent/IS7971A/is

Links

IS7971A 2004-01-14 2005-08-05 Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða IS7971A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/000955 WO2004064788A2 (en) 2003-01-14 2004-01-14 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

Publications (1)

Publication Number Publication Date
IS7971A true IS7971A (is) 2005-08-05

Family

ID=36701521

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7971A IS7971A (is) 2004-01-14 2005-08-05 Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða

Country Status (1)

Country Link
IS (1) IS7971A (is)

Similar Documents

Publication Publication Date Title
IS7972A (is) Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða
NO20073482L (no) Fremgangsmåte til å stabilisere antidement medikament
DK2727583T3 (da) Lægemiddelbærer og lægemiddelbærerkit til at inhibere fibrose
IL181779A (en) A group of protein-based medical molecules
ATE419769T2 (de) System mit kapsel mit dichtmitteln
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
DK2609947T3 (da) Plasterlignende infusionsapparat
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
NL1029015A1 (nl) Therapeutische verbindingen.
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
ATE425952T1 (de) (biphenyl)carbonsauren und derivate davon
DK2471807T3 (da) Langtids-virkende polypeptider og fremgangsmåder til produktion og administration af samme
DE602004017700D1 (de) Transmukosen verabreichung
NO20053119D0 (no) Farmasoytiske sarmmensetninger med fentanyl for intranasal administrasjon.
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
ATE397618T1 (de) Peptidcyclisierung
DK1809660T3 (da) Thymus-specifikt protein
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
DE112006001343A5 (de) Patientenauflage
EA200500101A1 (ru) Лекарственное средство для коррекции патологических иммунных реакций
DE602004009268D1 (de) Verbinderhalterung
ATE546141T1 (de) Pharmazeutisches injektionspräparat
IS7971A (is) Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða
PL1753412T3 (pl) Samorozgrzewający plaster farmaceutyczny
DK1729734T3 (da) Spröjtetörrede farmaceutiske præparater